Botulinum toxin type A versus oral anticholinergic medication cost-effectiveness for the treatment of neurogenic detrusor overactivity.

Truzzi J1, Gonçalves L2, Guida Jr R3, Takemoto M4, Fernandes R4

Abstract Category

Detrusor Overactivity

Abstract 336
Non-Discussion Posters
Scientific Non Discussion Poster Session 29
1. Federal University of São Paulo, 2. Federal Hospital Ipanema- Rio de Janeiro, 3. Hospital Servidores Públicos do Estado - Rio de Janeiro, 4. ANOVA Knowledge Translation
Links

Abstract